Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


7 Cephalalgia
5 Headache
1 Neurology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. INDELICATO E, Nachbauer W, Eigentler A, Donnemiller E, et al
    Ten years of follow-up in a large family with familial hemiplegic migraine type 1: Clinical course and implications for treatment.
    Cephalalgia. 2017 Jan 1:333102417715229. doi: 10.1177/0333102417715229.
    PubMed     Text format     Abstract available

  2. VECCHIO E, Gentile E, Franco G, Ricci K, et al
    Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls.
    Cephalalgia. 2017 Jan 1:333102417728748. doi: 10.1177/0333102417728748.
    PubMed     Text format     Abstract available

  3. GUERRERO-PERAL AL, Ruiz M, Baron J, Palacios-Cena M, et al
    Roller pressure algometry as a new tool for assessing dynamic pressure sensitivity in migraine.
    Cephalalgia. 2017 Jan 1:333102417729114. doi: 10.1177/0333102417729114.
    PubMed     Text format     Abstract available

  4. LISICKI M, D'Ostilio K, Erpicum M, Schoenen J, et al
    Sunlight irradiance and habituation of visual evoked potentials in migraine: The environment makes its mark.
    Cephalalgia. 2017 Jan 1:333102417730128. doi: 10.1177/0333102417730128.
    PubMed     Text format     Abstract available

  5. AMIN FM, Hougaard A, Magon S, Sprenger T, et al
    Altered thalamic connectivity during spontaneous attacks of migraine without aura: A resting-state fMRI study.
    Cephalalgia. 2017 Jan 1:333102417729113. doi: 10.1177/0333102417729113.
    PubMed     Text format     Abstract available

  6. CHENG CY, Cheng HM, Chen SP, Chung CP, et al
    White matter hyperintensities in migraine: Clinical significance and central pulsatile hemodynamic correlates.
    Cephalalgia. 2017 Jan 1:333102417728751. doi: 10.1177/0333102417728751.
    PubMed     Text format     Abstract available

  7. GIL-GOUVEIA R, Martins IP
    Clinical description of attack-related cognitive symptoms in migraine: A systematic review.
    Cephalalgia. 2017 Jan 1:333102417728250. doi: 10.1177/0333102417728250.
    PubMed     Text format     Abstract available


  8. WOOLLEY JM, Bonafede MM, Maiese BA, Lenz RA, et al
    Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
    Headache. 2017 Aug 26. doi: 10.1111/head.13157.
    PubMed     Text format     Abstract available

    A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey.
    Headache. 2017;57:1284-1285.
    PubMed     Text format    

  10. KAWATA AK, Hsieh R, Bender R, Shaffer S, et al
    Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
    Headache. 2017 Aug 30. doi: 10.1111/head.13162.
    PubMed     Text format     Abstract available

  11. COHEN JM, Dodick DW, Yang R, Newman LC, et al
    Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
    Headache. 2017 Sep 1. doi: 10.1111/head.13156.
    PubMed     Text format     Abstract available

  12. YUAN H, Silberstein SD
    Histamine and Migraine.
    Headache. 2017 Sep 1. doi: 10.1111/head.13164.
    PubMed     Text format     Abstract available


  13. FERRONI P, Barbanti P, Aurilia C, Egeo G, et al
    Procoagulant imbalance in premenopausal women with chronic migraine.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004435.
    PubMed     Text format    

    PLoS One

  14. NWOSU BU, Maranda L, Candela N
    Vitamin D status in pediatric irritable bowel syndrome.
    PLoS One. 2017;12:e0172183.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.